Can mass spectrometry imaging replace the clinical pathologist's interpretation?

It cannot and should not. MSI provides molecular spatial distribution as supplementary evidence; formal diagnosis still relies on standard workflows such as histological morphology and IHC; it is strong in discovery and complementation.

In which steps is MSI most often used in clinical pathology?

Mainly for disease biomarker discovery, early identification, tumor grading, hormone-receptor-status related molecular research, and in-situ analysis of bacteria/microbe-related pathology.

Why does the clinical pathology scenario value matrix-free?

Pathology samples often require subsequent H&E or IHC validation; matrix-free eliminates spraying optimization, avoids matrix-peak interference, and the section remains intact after imaging for continued staining.

Can H&E still be done after imaging?

Yes. The Neo-Source DPI explicitly supports keeping the tissue section intact after imaging for continued H&E pathological testing, enabling registration between imaging and histology.

Application · Mass Spectrometry Imaging

Clinical Pathology Diagnosis Applications: Overlaying a Molecular Map Under the Microscope

Clinical pathology diagnosis relies on histological morphology, but for many diseases, molecular changes have already occurred before morphological changes. Clinical pathology diagnosis applications use mass spectrometry imaging (MSI) to present in-situ the distribution of molecules such as lipids, metabolites, drugs and peptides on sections that preserve tissue structure, providing 'beyond-morphology' molecular evidence for pathological diagnosis.

Table of Contents
1. Positioning of MSI in Clinical Pathology 2. Assisting Tumor Grading and Hormone-Receptor Status 3. Microbiology, Bacteria and Infection-Related Pathology 4. Integration Boundaries with Existing Pathology Workflows

Clinical Pathology Diagnosis Applications: Overlaying a Molecular Map Under the Microscope — schematic diagram

1. Positioning of MSI in Clinical Pathology

The application notes of the Neo-Source MSI DPI list pathology diagnosis as a key area, covering disease biomarker discovery, early diagnosis, clinical pathology research, bacterial analysis, microbial imaging, determining tumor grade, hormone-receptor status, gene-chip detection, cell biology and microbial ecology. MSI provides molecular-species and coordinate information that can be registered with H&E and IHC.

Its engineering advantages fit pathology: matrix-free, low ion suppression, tissue analyzed directly; 20–200 μm adjustable resolution; the section remains intact after imaging for continued H&E pathological testing.

2. Assisting Tumor Grading and Hormone-Receptor Status

Determining tumor grade and judging hormone-receptor status are key steps in clinical pathology. By comparing molecular spectral differences between tumor and paratumor regions, MSI can lock molecules specifically enriched or absent as potential grading and receptor-related biomarkers. In the DPI melanocytic nevus case, the characteristic molecule distribution highly matched the H&E nevus region, exactly reflecting this approach.

It must be clear: MSI is mostly at the research and translation stage; entering formal diagnosis still requires standardization, cohort validation and regulatory approval; it already has value in 'assisting biomarker discovery', 'explaining mechanisms' and 'complementing existing diagnosis'.

3. Microbiology, Bacteria and Infection-Related Pathology

The DPI application notes also include bacterial analysis, microbial imaging and microbial ecology as pathology-related directions. For infection- or microbiota-related samples, MSI can distinguish different microorganisms or their metabolic features in-situ in tissue, assisting understanding of infection distribution and microecological structure.

Matrix-free preparation makes such diverse and complex sample-preparation scenarios easier to deploy: the two Neo-Source imaging sources are matrix-free and measure on demand, allowing pathology and testing personnel without MSI expertise to get started relatively quickly.

4. Integration Boundaries with Existing Pathology Workflows

MSI is not to replace the microscope or IHC, but to complement. In practice, MSI sections are often registered with adjacent H&E/IHC sections, overlaying molecular signals onto histological structures to form dual 'morphology + molecule' interpretation.

DPI is engineered to be compatible with mainstream mass spectrometers from Agilent, AB SCIEX and Thermo, and provides a self-developed titanium-alloy ion transfer tube that does not damage the sample at the front end and is detachable for cleaning, supporting stable and reproducible clinical-pathology-related imaging research.

Frequently Asked Questions (FAQ)

Can mass spectrometry imaging replace the clinical pathologist's interpretation?: It cannot and should not. MSI provides molecular spatial distribution as supplementary evidence; formal diagnosis still relies on standard workflows such as histological morphology and IHC; it is strong in discovery and complementation.
In which steps is MSI most often used in clinical pathology?: Mainly for disease biomarker discovery, early identification, tumor grading, hormone-receptor-status related molecular research, and in-situ analysis of bacteria/microbe-related pathology.
Why does the clinical pathology scenario value matrix-free?: Pathology samples often require subsequent H&E or IHC validation; matrix-free eliminates spraying optimization, avoids matrix-peak interference, and the section remains intact after imaging for continued staining.
Can H&E still be done after imaging?: Yes. The Neo-Source DPI explicitly supports keeping the tissue section intact after imaging for continued H&E pathological testing, enabling registration between imaging and histology.

Get Specifications & Quotation

To obtain detailed specifications, compatible models, or a quotation for the MSI LDPI / DPI full series imaging ion sources, visit the Neo-Source official website, or contact the official team for compatibility advice tailored to your mass spectrometer (Agilent / SCIEX / Thermo and other mainstream MS).

DPI Dual-Photoionization Imaging Source Neo-Source MSI LDPI Laser Desorption Photoionization imaging ion source MSI in Pathological Diagnosis: Overlaying a Molecular Map Under the Microscope Pathology Imaging: Overlaying a Molecular Map Under the Microscope Clinical Pathology Diagnosis Applications: Overlaying a Molecular Map Under the Microscope

← Back to MSI Ion Source Knowledge Hub